Big Sioux Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$318K Sell
1,214
-715
-37% -$183K 0.15% 69
2026
Q2
$485K Buy
1,929
+131
+7% +$28.2K 0.29% 36
2026
Q1
$391K Sell
1,798
-33
-2% -$7.32K 0.25% 44
2025
Q4
$418K Buy
+1,831
New +$417K 0.28% 38

Other funds holding ABBV

Big Sioux Wealth Management's ABBV Position: Q3 2026 in Review

Big Sioux Wealth Management reduced its AbbVie (ABBV) stake by 37% in Q3 2026, selling an estimated $183K and leaving 1,214 shares worth $318K. The position accounts for 0.15% of the portfolio, ranked #69.

Big Sioux Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $485K in Q2 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Big Sioux Wealth Management held 1,214 shares of AbbVie worth $318K as of Q3 2026.
  • Big Sioux Wealth Management sold 715 AbbVie shares in Q3 2026, an estimated $183K.
  • AbbVie made up 0.15% of Big Sioux Wealth Management's portfolio in Q3 2026, its #69 holding.
  • Big Sioux Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Big Sioux Wealth Management's AbbVie position peaked at $485K in Q2 2026.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.